WEBULL
News
KYKOY
16.50
NaN%
--
Kura Oncology wins FDA approval for leukemia drug
Seeking Alpha · 11/13 15:28
Weekly Report: what happened at KYKOY last week (0908-0912)?
Weekly Report · 09/15 11:23
Amgen, Kyowa Kirin announce long-term Phase 3 data for eczema drug
Seeking Alpha · 09/09 11:08
Weekly Report: what happened at KYKOY last week (0901-0905)?
Weekly Report · 09/08 11:25
Weekly Report: what happened at KYKOY last week (0825-0829)?
Weekly Report · 09/01 11:20
Weekly Report: what happened at KYKOY last week (0818-0822)?
Weekly Report · 08/25 11:32
Weekly Report: what happened at KYKOY last week (0811-0815)?
Weekly Report · 08/18 11:23
Weekly Report: what happened at KYKOY last week (0804-0808)?
Weekly Report · 08/11 11:31
Weekly Report: what happened at KYKOY last week (0728-0801)?
Weekly Report · 08/04 11:33
Weekly Report: what happened at KYKOY last week (0721-0725)?
Weekly Report · 07/28 11:34
GSK wins EU approval for drug combos containing blood cancer drug Blenrep
Seeking Alpha · 07/24 16:29
Weekly Report: what happened at KYKOY last week (0714-0718)?
Weekly Report · 07/21 11:23
Weekly Report: what happened at KYKOY last week (0707-0711)?
Weekly Report · 07/14 11:34
Weekly Report: what happened at KYKOY last week (0630-0704)?
Weekly Report · 07/07 11:24
Weekly Report: what happened at KYKOY last week (0623-0627)?
Weekly Report · 06/30 11:31
Weekly Report: what happened at KYKOY last week (0616-0620)?
Weekly Report · 06/23 11:23
Weekly Report: what happened at KYKOY last week (0609-0613)?
Weekly Report · 06/16 11:30
Kura Oncology rises after new early-stage trial data for leukemia therapy
Seeking Alpha · 06/12 12:38
Weekly Report: what happened at KYKOY last week (0602-0606)?
Weekly Report · 06/09 11:32
Weekly Report: what happened at KYKOY last week (0526-0530)?
Weekly Report · 06/02 11:41
More
Webull provides a variety of real-time KYKOY stock news. You can receive the latest news about Kyowa Hakko through multiple platforms. This information may help you make smarter investment decisions.
About KYKOY
Kyowa Kirin Co Ltd is a Japan-based company engaged in the manufacture and sale of medical drugs. The Company operates in Pharmaceuticals business segment. The Company engages in the research, development, manufacture, sale, and import & export of prescription pharmaceuticals. The Company has drug discovery technologies in antibody therapeutics and hematopoietic stem cell gene therapy. Its development pipeline includes AMG531 for aplastic anemia untreated with immunosuppressive therapy, KHK4083/AMG 451 for moderate to severe atopic dermatitis, KHK4083/AMG 451 for moderate to severe asthma, and KK2845 for acute myeloid leukemia and others. In addition, through its subsidiaries, the Company develops, manufactures, markets, and contracts out biosimilar pharmaceuticals, and engages in wholesale and retail sales and insurance agency business. The Company operates in Japan and overseas.